Donald L Fine

Summary

Affiliation: DynPort Vaccine Company LLC
Country: USA

Publications

  1. ncbi request reprint Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 25:1868-76. 2007
  2. doi request reprint Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thormas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 26:3497-506. 2008
  3. pmc A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    J Virol Methods 163:424-32. 2010
  4. pmc Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus
    Shannon S Martin
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 28:3143-51. 2010
  5. pmc Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine
    Shannon S Martin
    DynPort Vaccine Company LLC DVC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 27:6814-23. 2009
  6. pmc Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
    Shannon S Martin
    DynPort Vaccine Company LLC DVC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 28:1031-40. 2010

Detail Information

Publications6

  1. ncbi request reprint Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 25:1868-76. 2007
    ..The second study supported that repeat dosing resulted in an increase in serum neutralizing antibody to TrD...
  2. doi request reprint Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thormas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 26:3497-506. 2008
    ..V3526 was immunogenic and essentially nonneurovirulent when administered via the clinically relevant subcutaneous route...
  3. pmc A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)
    Donald L Fine
    DynPort Vaccine Company LLC DVC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    J Virol Methods 163:424-32. 2010
    ..The combination of in vitro and in vivo assays provides a practical approach to optimize manufacturing process parameters for development of other inactivated viral vaccines...
  4. pmc Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus
    Shannon S Martin
    DynPort Vaccine Company LLC, A CSC Company, 64 Thomas Johnson Drive, Frederick, MD 21702, USA
    Vaccine 28:3143-51. 2010
    ..These data support further evaluation of fV3526 formulations as a next generation VEEV vaccine...
  5. pmc Telemetric analysis to detect febrile responses in mice following vaccination with a live-attenuated virus vaccine
    Shannon S Martin
    DynPort Vaccine Company LLC DVC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 27:6814-23. 2009
    ..From these studies, we conclude, outbred mouse strains implanted with telemeters are a sensitive model for predicting responses in humans following vaccination...
  6. pmc Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
    Shannon S Martin
    DynPort Vaccine Company LLC DVC, A CSC Company, Frederick, MD 21702, USA
    Vaccine 28:1031-40. 2010
    ..IM administration of gV3526 formulated with either CpG or CpG plus Alhydrogel further augmented the immune response in mice and resulted in 100% protection against aerosol challenge...